New amendment allows BC optometrists treat glaucoma

Article

The British Columbia Association of Optometrists (BCAO) has added to the Amendments to the Optometrists Regulation to allow optometrists to treat glaucoma.

In a move that will make the treatment of glaucoma easier and more efficient in British Columbia, BC Doctors of Optometry will now be able to prescribe medications for the treatment of glaucoma. The addition to the Amendments to the Optometrists Regulation started to take effect on August 2, 2012. Prior to this move, it wasn't uncommon for a patient to need to travel over one thousand kilometers to receive treatment for glaucoma.

Dr. Surginder Sahora, the president of the British Columbia Association of Optometrists (BCAO), commented on the change,

"By allowing Doctors of Optometry to prescribe anti-glaucoma medications, patients will have greater access to timely and appropriate eye care in all areas of the province. Doctors of Optometry are educated and certified to diagnose and to prescribe treatment for glaucoma. The recent changes allow them to practice what they are already certified to do."

For more information on the BC authorization to treat glaucoma, read the full press release.


Related Articles

British Columbia's optometrists are angling for glaucoma priviledges (May 1, 2012)

Recent Videos
In 2 weeks, the study participant's dry eye symptoms improved from 76 to 43 on a 0-100 rating scale, according to Marc-Matthias Schulze, PhD, Dipl Ing.
Eye care practitioners reported moderate to high satisfaction with lifitegrast's ability to improve signs of dry eye, according to Melissa Barnett, OD, FAAO, FSLS.
Neda Gioia, OD, CNS, FOWNS, details the positive feedback gained so far from other optometrists that have been prescribing the NutriTears supplement to their dry eye patients.
Damaris Raymondi, OD, FAAO, highlighted the importance of building patient-doctor trust to learn about these practices, which can include non-traditional treatments like chamomile or manuka honey eye drops.
Noreen Shaikh, OD, Magdalena Stec, OD, FAAO, and Brenda Bohnsack, MD, PhD, emphasize that collaboration and communication are key to proper diagnosis and treatment.
Cecilia Koetting, OD, FAAO, DipABO, cited data from a recent student that found that presbyopia treatment with 0.4% pilocarpine led to up to 86% of patients achieving 20/40 or better.
Kerry Giedd, OD, MS, FAAO, was 1 of 20 investigators around the country for a study evaluating the daily disposable contact lens.
According to A. Paul Chous, MA, OD, FAAO, optometrists have an important opportunity to educate patients in their chairs about diabetes.
David Geffen, OD, FAAO, gave a poster presentation titled "Revolutionizing Comfort: Unveiling the Potential of Perfluorohexyloctane Eyedrops for Contact Lens Wearers" at this year's Academy meeting.
Jessica Steen, OD, FAAO, Dipl-ABO, discussed ophthalmic considerations for patients undergoing treatment with antibody drug conjugates for gynecologic cancers at this year's conference.
© 2024 MJH Life Sciences

All rights reserved.